| pubmed-article:9413971 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9413971 | lifeskim:mentions | umls-concept:C0184661 | lld:lifeskim |
| pubmed-article:9413971 | lifeskim:mentions | umls-concept:C0009924 | lld:lifeskim |
| pubmed-article:9413971 | lifeskim:mentions | umls-concept:C1523987 | lld:lifeskim |
| pubmed-article:9413971 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:9413971 | pubmed:dateCreated | 1998-1-12 | lld:pubmed |
| pubmed-article:9413971 | pubmed:abstractText | Renal failure due to iodinated contrast media is a serious complication of peripheral angiography in patients with impaired renal function. Gadolinium based agents which are widely used in magnetic resonance imaging have no adverse renal toxicity at recommended doses. These agents have sufficient radiographic density to be seen using digital subtraction equipment. We describe the use of undiluted gadopentate dimeglumine as the radiographic contrast agent in two patients who underwent complex interventional procedures. | lld:pubmed |
| pubmed-article:9413971 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9413971 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9413971 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9413971 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9413971 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9413971 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9413971 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:9413971 | pubmed:issn | 0009-9260 | lld:pubmed |
| pubmed-article:9413971 | pubmed:author | pubmed-author:IrvineA TAT | lld:pubmed |
| pubmed-article:9413971 | pubmed:author | pubmed-author:JaroszJ MJM | lld:pubmed |
| pubmed-article:9413971 | pubmed:author | pubmed-author:HatrickA GAG | lld:pubmed |
| pubmed-article:9413971 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9413971 | pubmed:volume | 52 | lld:pubmed |
| pubmed-article:9413971 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9413971 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9413971 | pubmed:pagination | 948-52 | lld:pubmed |
| pubmed-article:9413971 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:9413971 | pubmed:meshHeading | pubmed-meshheading:9413971-... | lld:pubmed |
| pubmed-article:9413971 | pubmed:meshHeading | pubmed-meshheading:9413971-... | lld:pubmed |
| pubmed-article:9413971 | pubmed:meshHeading | pubmed-meshheading:9413971-... | lld:pubmed |
| pubmed-article:9413971 | pubmed:meshHeading | pubmed-meshheading:9413971-... | lld:pubmed |
| pubmed-article:9413971 | pubmed:meshHeading | pubmed-meshheading:9413971-... | lld:pubmed |
| pubmed-article:9413971 | pubmed:meshHeading | pubmed-meshheading:9413971-... | lld:pubmed |
| pubmed-article:9413971 | pubmed:meshHeading | pubmed-meshheading:9413971-... | lld:pubmed |
| pubmed-article:9413971 | pubmed:meshHeading | pubmed-meshheading:9413971-... | lld:pubmed |
| pubmed-article:9413971 | pubmed:meshHeading | pubmed-meshheading:9413971-... | lld:pubmed |
| pubmed-article:9413971 | pubmed:meshHeading | pubmed-meshheading:9413971-... | lld:pubmed |
| pubmed-article:9413971 | pubmed:meshHeading | pubmed-meshheading:9413971-... | lld:pubmed |
| pubmed-article:9413971 | pubmed:meshHeading | pubmed-meshheading:9413971-... | lld:pubmed |
| pubmed-article:9413971 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9413971 | pubmed:articleTitle | Gadopentate dimeglumine as an alternative contrast agent for use in interventional procedures. | lld:pubmed |
| pubmed-article:9413971 | pubmed:affiliation | Department of Radiology, Guy's and St Thomas' NHS Trust, St Thomas' Hospital, London, UK. | lld:pubmed |
| pubmed-article:9413971 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9413971 | pubmed:publicationType | Case Reports | lld:pubmed |
